Why is Torrent Pharma falling/rising?

As of 03-Jul, Torrent Pharmaceuticals Ltd. is currently priced at 3,340.90, reflecting a decrease of 10.3 points or 0.31%. The stock has been underperforming recently, having fallen for the last two consecutive days with a total decline of 2.12%. Despite this short-term downturn, the stock has shown positive performance over the past week and month, with returns of 3.98% and 6.44%, respectively. However, it is noteworthy that the stock's delivery volume has significantly decreased by 60.81% compared to the five-day average, indicating a decline in investor participation. On a positive note, Torrent Pharma has demonstrated strong management efficiency, a low debt-to-EBITDA ratio, and consistent positive results over the last seven quarters, which could support its long-term stability.
In the broader market context, Torrent Pharmaceuticals has outperformed the Sensex over the past year with a return of 17.65% compared to the benchmark's 4.07%. However, in the short term, the stock's performance has lagged behind the benchmark, as it has underperformed its sector by 0.79%. While the stock is trading above its moving averages, the recent decline in delivery volume and consecutive price drops may be causing concern among investors, despite the company's strong fundamentals and high institutional holdings. This combination of factors suggests that while the long-term outlook remains positive, short-term pressures are currently affecting the stock's price.